Literature DB >> 5645701

Inorganic phosphate treatment of hypercalcemia.

S G Massry, E Mueller, A G Silverman, C R Kleeman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645701

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  8 in total

1.  Phosphate treatment of hypercalcemia.

Authors:  P Corr
Journal:  Calif Med       Date:  1970-02

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

3.  An acceptable slow-release phosphate preparation "slow P".

Authors:  V Parsons; A Porter; C Lund
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

4.  [Phosphate treatment in hypercalcemia].

Authors:  H J Kistler; W Neubauer
Journal:  Klin Wochenschr       Date:  1970-06-15

Review 5.  The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. I.

Authors:  C R Kleeman; S G Massry; J W Coburn
Journal:  Calif Med       Date:  1971-03

6.  Stimulation of bone formation in vivo by phosphate supplementation.

Authors:  W H Harris; R P Heaney; L A Davis; E H Weinberg; R D Coutts; A L Schiller
Journal:  Calcif Tissue Res       Date:  1976-11-24

7.  Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms.

Authors:  J W Coburn; S G Massry
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

Review 8.  Hypercalcemia and cancer: an update.

Authors:  T M Murray; R G Josse; J N Heersche
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.